Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy

…, A Perkowska-Ptasińska, T Bączkowska… - Nature …, 2023 - nature.com
IgA nephropathy (IgAN) is a progressive form of kidney disease defined by glomerular
deposition of IgA. Here we performed a genome-wide association study of 10,146 kidney-biopsy-…

[HTML][HTML] Evaluation of Long-Term Outcomes of Direct Acting Antiviral Agents in Chronic Kidney Disease Subjects: A Single Center Cohort Study

…, K Czarnecka, O Tronina, T Bączkowska… - Journal of Clinical …, 2023 - mdpi.com
Background: The chronic kidney disease (CKD) population, including kidney transplant
recipients (KTRs) and subjects on renal replacement therapy, is particularly vulnerable to …

[HTML][HTML] Fire safety of healthcare units in conditions of oxygen therapy in CoViD-19: empirical establishing of effects of elevated oxygen concentrations

…, N Tuśnio, P Wolny, D Siuta, J Trzebicki, T Bączkowska… - Sustainability, 2022 - mdpi.com
Large-scale usage of oxygen therapy (OT) may lead to increased oxygen concentrations (OC)
in places where COVID-19 patients are treated. The aim of the study was to establish in …

GWAS defines pathogenic signaling pathways and prioritizes drug targets for IgA nephropathy

…, A Perkowska-Ptasińska, T Bączkowska… - medRxiv, 2021 - medrxiv.org
IgA nephropathy (IgAN) is a progressive form of kidney disease defined by glomerular deposition
of IgA. We performed a genome-wide association study involving 10,146 kidney biopsy…

Multidirectional facets of obesity management in the metabolic syndrome population after liver transplantation

…, P Czarnecka, O Tronina, T Bączkowska… - Immunity …, 2022 - Wiley Online Library
The obesity pandemic has resulted in an increasing demand for liver transplantation and
has significantly altered the profile of liver transplant candidates in addition to affecting …

[PDF][PDF] Outcomes of COVID-19 in hospitalized kidney and liver transplant recipients: a single-center experience

…, M Gronkiewicz, L Jureczko, T Bączkowska - Pol Arch Intern …, 2021 - scholar.archive.org
INTROduCTION Solid organ transplant recipients seem to be more susceptible to severe
COVID‑19. ObjECTIvEs Our study aimed to assess the clinical outcomes of COVID‑19 in …

[HTML][HTML] De Novo Metabolic Syndrome 1 Year after Liver Transplantation and Its Association with Mid-and Long-Term Morbidity and Mortality in Liver Recipients

…, P Czarnecka, O Tronina, T Bączkowska… - Journal of Clinical …, 2024 - mdpi.com
Background: Metabolic syndrome (MS) constitutes an important source of cardiovascular-
and cancer-related morbidity and mortality in the general population. Limited information is …

Different relevance of peripheral, central or nighttime blood pressure measurements in the prediction of chronic kidney disease progression in patients with mild or no …

…, K Kwiecień, M Adamczak, T Bączkowska… - Kidney and Blood …, 2018 - karger.com
Background/Aims: Arterial hypertension is one of the leading factors aggravating the course
of chronic kidney disease (CKD). It seems that the novel parameters used in the assessment …

[HTML][HTML] Kidney and Liver Tissue Tacrolimus Concentrations in Adult Transplant Recipients—The Influence of the Whole Blood and Tissue Concentrations on …

M Bodnar-Broniarczyk, M Durlik, T Bączkowska… - Pharmaceutics, 2021 - mdpi.com
Tacrolimus (TAC) has a narrow therapeutic index and highly variable pharmacokinetic
characteristics. Close monitoring of the TAC concentrations is required in order to avoid the risk of …

[HTML][HTML] MASH Continues as a Significant Burden on Metabolic Health of Liver Recipients

…, P Czarnecka, O Tronina, T Bączkowska… - Transplantation …, 2024 - Elsevier
Background Metabolic complications are a recognized health concern in liver transplant
recipients that result in inferior patient-reported outcomes. Patients with MASH are known to be …